Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

Published:2017-06 Issue: Volume:Volume 10 Page:3177-3186
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Yao James,Chan Jennifer A,Mita Alain,Kundu Madan G,Hermosillo Reséndiz Karina,Hu Ke,Ravichandran Shoba,Strosberg Jonathan,Wolin Edward M.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story;Journal of Endocrinological Investigation;2023-08-15

2. Resistance of neuroendocrine tumours to somatostatin analogs;Expert Review of Endocrinology & Metabolism;2023-01-02

3. Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors;Cancers;2022-09-29

4. Target therapies plus somatostatin analogs in NETs: a network meta-analysis;Endocrine-Related Cancer;2021-07-01

5. The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors;Molecular and Cellular Endocrinology;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP